KORU MEDICAL SYSTEMS, INC.

Analyst Reco. KORU Medical Systems, Inc.

Equities

KRMD

US7599101026

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
2.19 ^USD	0.00%		+5.29%	-10.79%

Mar. 13	Transcript : KORU Medical Systems, Inc., Q4 2023 Earnings Call, Mar 13, 2024
Mar. 13	KORU Medical Systems, Inc. Enters into Loan and Security Agreement with HSBC Ventures USA Inc	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lake Street Starts Repro Med Systems at Buy	23-09-07	MT
B. Riley Starts Repro Med Systems at Buy With $4.50 Price Target, Says Risk/Reward Becoming More Favorable	23-09-07	MT
Piper Sandler Adjusts Repro Med Systems Price Target to $4.50 From $3.50, Maintains Overweight Rating	23-01-06	MT
Canaccord Genuity Upgrades Repro Med Systems to Buy Rating From Hold, Adjusts Price Target to $4 From $3	22-11-10	MT
Piper Sandler Upgrades Repro Med Systems to Overweight From Neutral, Adjusts Price Target to $3.50 From $3	22-11-10	MT
REPRO MED : Canaccord Genuity Downgrades Repro Med Systems to Hold From Buy; Price Target is $5	21-01-26	MT
REPRO MED : Piper Sandler Downgrades Repro Med Systems to Neutral From Overweight, Adjusts Price Target to $4.50 From $9	21-01-26	MT
REPRO MED : Canaccord Genuity Adjusts Repro Med Systems PT to $10 From $13, Maintains Buy Rating	20-11-05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer